Target intelligence / Profile preview

Staphylococcus genus bacterium

Molecular classification
Other (Bacterium; not a molecular target such as a receptor, enzyme, transporter, etc.)
01

Overview

Staphylococcus is a **genus of Gram-positive cocci** that typically form clusters resembling grape bunches. Members are non-motile, non-spore-forming facultative anaerobes found commonly on human skin and mucous membranes. The most clinically significant species are *Staphylococcus aureus*, which can cause severe infections such as wound infections, sepsis, pneumonia, food poisoning, toxic shock syndrome and more; *S. epidermidis*, an opportunistic pathogen especially relevant in immunocompromised patients or those with indwelling devices; and *S. saprophyticus*, associated with urinary tract infections. The term "Staphylococcus genus bacteria" refers to an entire group containing over fifty recognized species rather than a single molecular target or protein—thus it is **not considered a therapeutic target** like receptors or enzymes would be.[1][2][3] Instead, individual proteins within these bacteria may serve as drug targets. Some staphylococci produce toxins contributing to disease severity. A major public health concern is the emergence of antibiotic-resistant strains such as methicillin-resistant *S. aureus* (**MRSA**) and vancomycin-resistant *S. aureus* (**VRSA**), which complicate treatment options.[4] Diagnosis relies on culture characteristics and biochemical tests including coagulase activity.[5] Treatment depends on antibiotic susceptibility profiles but may involve penicillins/cephalosporins unless resistance dictates alternatives like vancomycin or linezolid.[6] Because "Staphylococcus genus bacteria" refers to an entire bacterial group—not a single molecule—it does **not fit standard definitions for drug targets**, making this entry incorrect if used where only molecular targets are appropriate. > “Assignment of a strain to the genus Staphylococcus requires it to be a Gram-positive coccus that forms clusters... All species grow in the presence of bile salts.” [1] > > “There are currently 53 recognised species... The staphylococci most frequently associated with human infection are S. aureus, S. epidermidis and S.saprophyticus.” [2] > > “Of significance to humans are various strains... While S.epidermidis is a mild pathogen...strains of S.aureus are major agents...” [4]

Other names
StaphylococcusStaphylococciStaph bacteriaGenus Staphylococcus
02

Mechanism of action

Not directly applicable at the genus level; for drugs targeting staphylococci in general: - Inhibition of cell wall synthesis (β-lactams like penicillins/cephalosporins/vancomycin) - Inhibition of protein synthesis (linezolid)[4][6]

03

Biological functions

Colonization of skin and mucous membranesOpportunistic infectionToxin production (e.g., enterotoxins, cytotoxins)Immune evasion mechanisms[1][4][6]
04

Disease associations

Infection (including skin infections, bacteremia/sepsis, endocarditis, pneumonia)Food poisoningToxic shock syndrome[4][6]
05

Safety considerations

Antibiotic resistance (notably MRSA and VRSA)[4]Nosocomial transmission riskDifficulty eradicating colonization in healthcare settings
06

Interacting drugs

Penicillins (e.g., methicillin for S. aureus)

3 more in the full profile.

07

Biomarkers

Coagulase test for S. aureus identification[1][5]PCR-based detection of specific genes in certain species[2]

Beyond the preview

Go deeper on Staphylococcus genus bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus genus bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call